We observed that PI3K and PTEN mutations were mutually exclusive with FGFR1-4EBP1 amplification in both breast and lung cancer, suggesting their redundant requirement (Figure 1H and Figure S1D). This evidence concerns the gene FGFR1 and lung cancer.